{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:43:57Z","timestamp":1768034637337,"version":"3.49.0"},"reference-count":56,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T00:00:00Z","timestamp":1401148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p>PPAR\u03b2 enhances insulin sensitivity in adipocytes and skeletal muscle cells, but its effects on insulin signalling in endothelial cells are not known. We analysed the effects of the <jats:styled-content style=\"fixed-case\">PPAR<\/jats:styled-content>\u03b2\/\u03b4 (<jats:styled-content style=\"fixed-case\">PPAR<\/jats:styled-content>\u03b2) agonists, <jats:styled-content style=\"fixed-case\">GW<\/jats:styled-content>0742 and <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>165041, on impaired insulin signalling induced by high glucose in <jats:styled-content style=\"fixed-case\">HUVECs<\/jats:styled-content> and aortic and mesenteric arteries from diabetic rats.<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Approach<\/jats:title><jats:p>Insulin\u2010stimulated <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content> production, <jats:styled-content style=\"fixed-case\">Akt<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">Ser<\/jats:styled-content><jats:sup>473<\/jats:sup> and <jats:styled-content style=\"fixed-case\">eNOS<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">Ser<\/jats:styled-content><jats:sup>1177<\/jats:sup> phosphorylation, and reactive oxygen species (<jats:styled-content style=\"fixed-case\">ROS<\/jats:styled-content>) production were studied in <jats:styled-content style=\"fixed-case\">HUVECs<\/jats:styled-content> incubated in low\u2010 or high\u2010glucose medium. Insulin\u2010stimulated relaxations and protein phosphorylation in vessels from streptozotocin (<jats:styled-content style=\"fixed-case\">STZ<\/jats:styled-content>)\u2010induced diabetic rats were also analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">HUVECs<\/jats:styled-content> incubated in high\u2010glucose medium showed a significant reduction in insulin\u2010stimulated production of <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>. High glucose also reduced insulin\u2010induced <jats:styled-content style=\"fixed-case\">Akt<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">Ser<\/jats:styled-content><jats:sup>473<\/jats:sup> and <jats:styled-content style=\"fixed-case\">eNOS<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">Ser<\/jats:styled-content><jats:sup>1177<\/jats:sup> phosphorylation, increased <jats:styled-content style=\"fixed-case\">IRS<\/jats:styled-content>\u20101\u2010Ser<jats:sup>636<\/jats:sup> and <jats:styled-content style=\"fixed-case\">ERK<\/jats:styled-content>1\/2\u2010<jats:styled-content style=\"fixed-case\">Thr<\/jats:styled-content><jats:sup>183<\/jats:sup>\u2010<jats:styled-content style=\"fixed-case\">Tyr<\/jats:styled-content><jats:sup>185<\/jats:sup> phosphorylation and increased <jats:styled-content style=\"fixed-case\">ROS<\/jats:styled-content> production. The co\u2010incubation with the <jats:styled-content style=\"fixed-case\">PPAR<\/jats:styled-content>\u03b2 agonists <jats:styled-content style=\"fixed-case\">GW<\/jats:styled-content>0742 or <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>165041 prevented all these effects induced by high glucose. In turn, the effects induced by the agonists were suppressed when <jats:styled-content style=\"fixed-case\">HUVEC<\/jats:styled-content> were also incubated with the <jats:styled-content style=\"fixed-case\">PPAR<\/jats:styled-content>\u03b2 antagonist <jats:styled-content style=\"fixed-case\">GSK<\/jats:styled-content>0660, the pyruvate dehydrogenase kinase (<jats:styled-content style=\"fixed-case\">PDK<\/jats:styled-content>)4 inhibitor dichloroacetate or after knockdown of both <jats:styled-content style=\"fixed-case\">PPAR<\/jats:styled-content>\u03b2 and <jats:styled-content style=\"fixed-case\">PDK<\/jats:styled-content>4 with <jats:styled-content style=\"fixed-case\">siRNA<\/jats:styled-content>. The <jats:styled-content style=\"fixed-case\">ERK<\/jats:styled-content>1\/2 inhibitor <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>98059, <jats:styled-content style=\"fixed-case\">ROS<\/jats:styled-content> scavenger catalase, inhibitor of complex <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content> thenoyltrifluoroacetone or uncoupler of oxidative phosphorylation, carbonyl cyanide m\u2010chlorophenylhydrazone, also prevented glucose\u2010induced insulin resistance. In <jats:styled-content style=\"fixed-case\">STZ<\/jats:styled-content> diabetic rats, oral <jats:styled-content style=\"fixed-case\">GW<\/jats:styled-content>0742 also improved insulin signalling and the impaired <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\u2010mediated vascular relaxation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion and Implications<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">PPAR<\/jats:styled-content>\u03b2 activation <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> restores the endothelial function, preserving the insulin\u2010<jats:styled-content style=\"fixed-case\">Akt<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">eNOS<\/jats:styled-content> pathway impaired by high glucose, at least in part, through <jats:styled-content style=\"fixed-case\">PDK<\/jats:styled-content>4 activation.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bph.12646","type":"journal-article","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T11:43:17Z","timestamp":1392637397000},"page":"3089-3102","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["<scp>PPAR<\/scp>\u03b2 activation restores the high glucose\u2010induced impairment of insulin signalling in endothelial cells"],"prefix":"10.1111","volume":"171","author":[{"given":"A M","family":"Quintela","sequence":"first","affiliation":[{"name":"Department of Pharmacology University of Granada  18071 Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of Granada  18071 Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Piqueras","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Faculty of Medicine University of Valencia  Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"G\u00f3mez\u2010Guzm\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of Granada  18071 Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Haro","sequence":"additional","affiliation":[{"name":"Service of Gynecology Clinic Hospital of Granada  Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Zarzuelo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of Granada  18071 Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Cogolludo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology School of Medicine University Complutense of Madrid IdISSC and Ciber Enfermedades Respiratorias (CIBERES)  Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Sanz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Faculty of Medicine University of Valencia  Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Toral","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of Granada  18071 Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Romero","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of Granada  18071 Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"P\u00e9rez\u2010Vizca\u00edno","sequence":"additional","affiliation":[{"name":"Department of Pharmacology School of Medicine University Complutense of Madrid IdISSC and Ciber Enfermedades Respiratorias (CIBERES)  Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Duarte","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of Granada  18071 Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,5,27]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12448"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-1468"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e3283444b09"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.1.8536636"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0357-6"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2007.05.010"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-1211"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00431.2009"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.06.091"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.20.5.649"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.08.072"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2000.279.1.E11"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.01.099"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11235"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.7.8283"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.656"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.621854"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.159806"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2005.05.009"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.4.1157"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702329200"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.01.018"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0288"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01554-4"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.05.023"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2012.668491"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.6.8567"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e32819f8ecd"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/35008121"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.091021198"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST0340217"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0508284"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.05.045"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.12.006"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.11.040"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2006.109512"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0176"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210618200"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/414799a"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00050.2001"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0704"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.70.113006.100533"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0306981100"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00430.2005"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2008.07.003"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0117"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.6.1621"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-003-0018-9"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1887-z"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00269-1"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092952"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.09.053"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0490fje"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.174490"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.12646","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.12646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T03:24:40Z","timestamp":1696217080000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.12646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,27]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1111\/bph.12646"],"URL":"https:\/\/doi.org\/10.1111\/bph.12646","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,27]]},"assertion":[{"value":"2013-09-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-02-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}